Calumet Specialty Product Partners is a holding company. Through its subsidiaries, the company is an independent producer of hydrocarbon products in North America. In its specialty products segment, the company processes crude oil and other feedstocks into a variety of customized lubricating oils, white mineral oils, solvents, petrolatums and waxes. The company's specialty products are sold to customers who purchase them as raw material components for basic industrial, consumer and automotive goods. In its fuel products segment, the company processes crude oil into fuel and fuel-related products, including gasoline, diesel, jet fuel, asphalt and heavy fuel oils, and resells purchased crude oil to third party customers.

Donegal Group is an insurance holding company. Through its insurance subsidiaries, the company provides personal and commercial lines of property and casualty insurance. The company has three segments: its investment function, its commercial lines of insurance and its personal lines of insurance. The company's insurance operations consist of two segments: commercial lines of insurance and personal lines of insurance. The commercial lines its insurance subsidiaries write consist primarily of commercial automobile, commercial multi-peril and workers' compensation insurance. The personal lines its insurance subsidiaries write consist primarily of private passenger automobile and homeowner's insurance.

Ecolab is a provider of water, hygiene and energy technologies and services. The company's segments include: Global Industrial, which provides water treatment and process applications, and cleaning and sanitizing solutions in the manufacturing, food and beverage processing, chemical, power generation, pharmaceutical and commercial laundry industries; Global Institutional, which provides cleaning and sanitizing products to the foodservice, hospitality, lodging, healthcare, government, education and retail industries; and Global Energy, which serves the process chemicals and water treatment needs of the global petroleum and petrochemical industries in both upstream and downstream applications.

Fluent provides digital marketing services. The company primarily performs customer acquisition services by operating digital marketing campaigns, through which the company connects its advertiser clients with consumers. The company delivers data and performance-based marketing executions to its clients, across a range of industries, including Financial Services, Retail and Consumer, Media and Entertainment, Staffing and Recruitment and Marketing Services. The company provides performance marketing solutions to its clients based on their desired outcomes, or specific actions in their marketing funnels, including submission of a registration form, app installation or a completed transaction.

German American Bancorp is a financial holding company. Through its subsidiaries, the company operates banking offices, investment brokerage, and property and casualty insurance agency. The company's primary segments are: core banking, which involves accepting deposits from the general public and using such funds to originate consumer, commercial and agricultural, commercial and agricultural real estate, and residential mortgage loans; trust and investment advisory services, which involves providing trust, investment advisory, and brokerage services to customers; and insurance operations, which provides a range of personal and corporate property and casualty insurance products.

Insight Enterprises is a provider of digital technology, cloud/data center optimization, connected workforce, and supply chain optimization solutions and services. The company is organized in the following three operating segments, which are primarily defined by their related geographies: North America; Europe, Middle East and Africa (EMEA); and Asia-Pacific (APAC). The company's offerings in North America and certain countries in EMEA and APAC include a suite of information technology hardware, software and services solutions. The company's offerings in the remainder of its EMEA and APAC segments are primarily software and certain software-related services.

Neogen develops, manufactures, and markets a line of products for food and animal safety. The company's segments are: Food Safety, which is engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation; and Animal Safety, which is engaged in the development, production and marketing of products dedicated to animal safety, including a range of consumable products marketed to veterinarians and animal health product distributors, and provides genomic identification and related interpretive bioinformatic services.

Newpark Resources is engaged in providing products, rentals, and services primarily to the oil and natural gas exploration and production (E&P) industry. The company has two reportable segments: Fluids Systems, which provides customized drilling, completion, and stimulation fluids solutions to E&P customers; and Mats and Integrated Services, which provides composite mat rentals utilized for temporary worksite access, along with related site construction services to customers in various markets including E&P, electrical transmission & distribution, pipeline, solar, petrochemical, and construction industries across North America and Europe. The company also sells composite mats to customers around the world.

OncoCyte is focused on developing non-invasive molecular diagnostic tests for cancer diagnosis. The company is developing DetermaVu?, a non-invasive molecular lung cancer confirmatory diagnostic that can be administered to patients as a blood test. DetermaVu? utilizes proprietary sets of gene expression markers to help confirm whether lung nodules detected via Low Dose Computed Tomography scans, x-rays or other imaging are likely to be benign or malignant. DetermaVu? is based on the company's Immune System Interrogation approach that checks the body's immune system response to a specific disease by measuring differential RNA expression in patients with the disease versus patients without the disease.